progscrape: fiercepharma.com

Former CBER head Peter Marks says he blocked RFK Jr. from vaccine safety database before leaving FDA

5 days ago fiercepharma.com database vaccine

Zantac’s maker kept quiet about cancer risks for 40 years

2 years ago fiercepharma.com cancer

JAMA Study: "Although prices are often justified by the high cost of drug development, there is no evidence of an association between research and development costs and prices; rather, prescription drugs are priced in the United States primarily on the basis of what the market will bear."

8 years ago fiercepharma.com

What price MS therapy? Thanks to price hikes, $50K-plus, even for decades-old meds

9 years ago fiercepharma.com